Hemolytic Drugs Flashcards

1
Q

What is the goal of normal hemostasis?

A
  • prevent prolonged hemorrhage
  • prevent spontaneous thrombosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the stages of hemostasis?

A
  • Vasospasm
  • Platelet response
  • coagulation phase
  • clot dissolution (fibrinolysis)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What occurs during vasospasm?

A
  • vasoconstriction
  • sympathetics and local factors respond to restrict blood flow to the area
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What occurs during platelet response?

A
  • forms an initial plug immediately
  • platelets adhere to exposed collagen and damaged endothelium
  • platelet plug releases chemical mediators to recruit platelets, promote vasoconstriction and initiate the coagulation cascade
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What happen during the coagulation phase?

A
  • conversion of soluble fibrinogen to insoluble fibrin forming a net of organized protein around the platelet plug
  • if done correctly this phase results in a clot (thrombus)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What happens during clot dissolution/fibrinolysis?

A
  • wound healing and restoration of blood flow
  • dissolution of clot
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the main causes of excessive bleeding? (3)

A
  • platelet deficiency
  • clotting factor deficiency
  • fibrinolytic hyperactivity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the two natural forms of Vitamin K that exist?

A
  • K1: phytonadione (foods)
  • K2: menaquinone (intestinal bacteria)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the main mechanism of action of vitamin K?-

A
  • confers biological activity of multiple factors
  • SC is the recommended route because anaphylaxis and hematomas are possible
  • it is very fat soluble so considered to be safe
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

When would we use vitamin K?

A
  • vitamin k deficiency (rodenticide toxicity or sweet clover poisoning)
  • warfarin overdosing
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is Desmopressin acetate (DDAVP) used for?

A
  • increases Von Willebrand activity (helps platelets stick together)
  • used prophylactically to control capillary bleeding during surgery
  • injectable or nasal spray
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is Protamine Sulfate used for?

A
  • used to treat heparin overdoses (binds to heparin neutralizing its anticoagulant effect)
  • give IV slowly to avoid adverse reactions that include collapse
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What do we use fibrinolytic inhibitors for?

A
  • plasmin lyses fibrin and fibrinogen
  • a fibrinolytic inhibitor like Aminocaproic acid will block lysine binding sites, inhibiting plasmin
  • we would use these drugs for bleeding from fibrinolytic therapy or adjunct therapy-hemophiliacs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is thromboembolic disease?

A
  • thrombus formation of the “blood clot proper”
  • thromboemboli migration of thrombus in the body
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What does pathogenesis of thrombosis require?

A

Prothrombic factors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are some prothrombic factors?

A
  • local vessel injury
  • abnormal blood flow (stasis or turbulence)
  • altered blood coagulability
17
Q

What does an ideal systemic anticoagulant include?

A
  • prevents pathologic thrombosis
  • allow normal response to vascular injury and limit bleeding
18
Q

What is the mechanism of action of heparin?

A
  • Enhances the action of antithrombin III which inhibits activated clotting factors
19
Q

What do we primarily use heparin for?

A
  • initial treatment of thrombosis and thromboembolic disease
  • useful as an acute anticoagulant as it has rapid onset
  • prevents NEW thrombus formation only, will not lyse existing thrombus
20
Q

What are some adverse effects of heparin?

A
  • bleeding tendencies
  • 1.8-2.5X the normal mean aPTT
  • protamine sulfate can neutralize heparin in overdose
21
Q

What are some key characteristics of Enoxaparin?

A
  • systemic anticoagulant
  • low molecular weight heparin
  • used more commonly due to less bleeding tendencies, protamine sulfate is less active against LMW heparins, less risk of thrombocytopenia, improved pharmokinetics = can give sub q and longer half life
22
Q

What are the key characteristics about Warfarin?

A
  • systemic anticoagulant
  • oral anticoagulant - antagonizes vitamin K actions
  • injectable and oral formulations available
  • monitoring using international normalized ratio
23
Q

What are the adverse effects of Warfarin?

A
  • bleeding tendencies
  • serious bleeding requires fresh blood/plasma
  • warfarin crosses placenta therefore do not use in pregnancy (heparin does not cross placenta)
24
Q

What is the mechanism of action of Rivaroxaban?

A
  • selective factor Xa inhibitor
25
Q

What are the key characteristics of Rivaroxaban?

A
  • systemic anticoagulant
  • inactivate factor Xa directly
  • does not interact with ATIII and no thrombin activity
  • quick anticoagulant activity
  • predictable pharmokinetics
  • given orally
  • bleeding can occur
26
Q

What are the key characteristics of aspirin?

A
  • cyclooxygenase inhibitor
  • irreversibly binds cyclooxygenase-1
  • prevents thrombus and re-thrombosis formation
27
Q

What are some adverse effects of aspirin?

A
  • GI ulceration
  • renal damage
  • bleeding tendencies
28
Q

What are the key characteristics of clopidogrel?

A
  • ADP inhibitors
  • reduce platelet aggregation by inhibiting ADP pathways
  • “prodrug” which must be activated by liver P450 metabolism
  • routinely used for thromboembolic concerns in cats (HCM) and dogs (IMHA)
  • fairly safe
29
Q

What do fibrinolytic drugs do?

A

Rapidly lyse through thrombi by activating plasmin from clot bound plasminogen

30
Q

What are the key characteristics of tissue plasminogen activator?

A
  • proteases that bind fibrin
  • can preferentially activate clot bound plasminogen
  • short-half life = constant rate infusion
31
Q

What do we use tissue plasminogen activator for?

A

Thromboembolic therapy for canine pulmonary thromboembolism and feline saddle thrombis

32
Q

What are the adverse effects of tissue plasminogen activator?

A
  • reperfusion injury
  • bleeding tendencies
33
Q

What are the key characteristics of erythropoietin?

A
  • erythropoietin is made by the kidney in response to hypoxia
  • used commonly in anemias when there is chronic renal failure
  • iron supplementation advised with usage
  • increases hematocrit and hemoglobin in 2-4 weeks
34
Q

What are the adverse effects of erythropoietin?

A
  • hypertension
  • seizure
  • therapeutic failure from antibody formation (most common)